• This image shows H1 human embryonic stem cells (hESCs) expressing green fluorescent protein. Undifferentiated stem cells such as these provide the starting point for much of our research.

  • A hESC-derived megakaryocyte with positive staining for von Willebrand Factor (red), CD41 (green), and DAPI (blue) is shown. Mature megakaryocytes such as this one are responsible for producing blood platelets.

  • This Giemsa-stained peripheral blood smear shows a granulocyte in a sea of red blood cells. Inspired by the life saving component of red blood cells, we focus on using hES and iPS cells as a resource for donorless transfusable blood.

Welcome to Stem Cell and Regenerative Medicine International

SCRMI is an international biotechnology company engaged in the development of safe and effective cell-based therapies from human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs).